---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-002912"
form_type: "8-K"
ticker: "AVBP"
cik: "0001868279"
company_name: "ArriVent BioPharma, Inc."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:37:01.091900+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ArriVent BioPharma dismisses KPMG, appoints PwC as new auditor

## Summary
- Audit Committee dismissed KPMG on March 11, 2025; no disagreements on accounting principles or audit scope.
- Previously reported material weaknesses in internal controls (manual journal entries, nonroutine transactions) were remediated as of Dec 31, 2024.
- PricewaterhouseCoopers LLP appointed as independent auditor for fiscal year 2025.
- No consultations with PwC prior to appointment regarding any contentious accounting matters.

## SEC filing metadata
- accession: 0001558370-25-002912
- form_type: 8-K
- ticker: AVBP
- cik: 0001868279
- company_name: ArriVent BioPharma, Inc.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/0001558370-25-002912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/avbp-20250311x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-002912
- JSON: https://secwatch.observer/filing/0001558370-25-002912.json
- Plain text: https://secwatch.observer/filing/0001558370-25-002912.txt

## Key facts
- Auditor Changes
  ArriVent BioPharma, Inc. engaged PricewaterhouseCoopers LLP as its auditor.
  - Action: engagement
  - Auditor: PricewaterhouseCoopers LLP
  source text: On March 11, 2025, the Audit Committee appointed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/0001558370-25-002912-index.htm
- Auditor Changes
  ArriVent BioPharma, Inc. dismissed KPMG LLP as its auditor.
  - Action: dismissal
  - Auditor: KPMG LLP
  - Successor: PricewaterhouseCoopers LLP
  source text: On March 11, 2025, the Audit Committee (the “Audit Committee”) of the Board of Directors of ArriVent BioPharma, Inc. (the “Company”) approved the dismissal of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1868279/000155837025002912/0001558370-25-002912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.